Ricks argues that AI structure prediction solves only about one-thousandth of the problems in drug discovery, tempering hype around AI-designed drugs.

A machine can “predict things pretty well, like predicting the structure of a protein,” Ricks said according to Fortune, “but that is one maybe 1,000th of the kind of problems we face in drug discovery.”

Ricks says language models are not particularly good at biology and chemistry because they are trained on human language rather than the languages of science, and favors many narrow models.

language models are “not particularly good” at biology and chemistry because “they’re trained on the human language, not on the language of chemistry, physics, and biology.”

Ricks said now is the right time to merge Lilly's U.S. and international commercial units to build on momentum, and named Ilya Yuffa, who has run both, to lead global customer-facing operations.

To build on our momentum, now is the right time to consolidate our geographies for greater impact. Ilya has run both our international and U.S. businesses, and his range of experience and commitment to excellence make him uniquely qualified to lead our customer-facing operations worldwide.

David Ricks said only 3% to 10% of potential US patients access weight loss care, so the market has dramatic room to expand.

Lilly chief David Ricks, in a CNBC interview, said that only 3% to 10% of potential patients access weight loss care in the U.S., and he added that "room for expansion here of this market is dramatic."

David Ricks said only 3% to 10% of potential U.S. patients access weight loss care, so the market has dramatic room to expand.

only 3% to 10% of potential patients access weight loss care in the U.S., and he added that "room for expansion here of this market is dramatic."